Bausch Health Companies (BHC) Stock Price, News & Analysis

Company Overview

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Key Stats

• Today's Range: C$9.37 to C$9.57
• 50-Day Range: C$6.12 to C$9.66
• 52-Week Range: C$5.45 to C$13.74
• Volume: 102,834 shs
• Average Volume: 365,081 shs
• Market Capitalization: C$2.44 billion
• P/E Ratio: N/A
• Dividend Yield: 0.76%
• Price Target: N/A
• Consensus Rating: Hold

BHC Stock Analysis - Frequently Asked Questions

How have BHC shares performed this year?

Bausch Health Companies' stock was trading at C$11.62 at the beginning of the year. Since then, BHC stock has decreased by 19.2% and is now trading at C$9.39.

How do I buy shares of Bausch Health Companies?

Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Meta Platforms (META), Advanced Micro Devices (AMD), Enbridge (ENB), Shopify (SHOP), NVIDIA (NVDA) and Ford Motor (F).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:BHC
• CIK: N/A
• Web: www.valeant.com
• Phone: 514-744-6792
• Fax: N/A
• Employees: 19,900
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.68)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 1.69
• P/E Growth: 0.21
• Net Income: -C$125.65 million
• Net Margins: -1.88%
• Pretax Margin: N/A
• Return on Equity: 15.87%
• Return on Assets: 4.16%

Debt

• Debt-to-Equity Ratio: -1,831.94
• Current Ratio: 1.19
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: C$6.69 billion
• Price / Sales: 0.37
• Cash Flow: C$1.21 per share
• Price / Cash Flow: 7.76
• Book Value: C($0.66) per share
• Price / Book: -14.29

Miscellaneous

• Outstanding Shares: 260,055,152
• Free Float: N/A
• Market Cap: C$2.44 billion
• Optionable: Not Optionable
• Beta: 0.77